2007, Number 1
<< Back Next >>
Gac Med Mex 2007; 143 (1)
Carcinoma mucinoso (coloide) puro de la glándula mamaria masculina. Presentación de un caso de una variante poco común
Martínez-Consuegra N, Baquera-Heredia J, Robles-Vidal C, Zumarán-Cuéllar O, Ortiz-Hidalgo C
Language: Spanish
References: 17
Page: 79-81
PDF size: 76.60 Kb.
ABSTRACT
Pure mucinous (colloid, mucous) carcinoma of the male breast is an extremely rare neoplasm. We report the case of a 74-year old male who displayed a rapidly growing retroareolar tumor of the left breast. The patient underwent modified radical mastectomy. The tumor was well demarcated, had a soft consistency with a glistening gelatinous appearance. Histologically, the neoplasm corresponded to a pure mucinous carcinoma which is one of the most unusual subtypes, accounting for less than 2% of male breast carcinomas.
REFERENCES
Giordano SH. A review of the diagnosis and management of male breast cancer. The Oncologist 2005;10:471-479.
Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast Carcinoma in men a population.based-study. Cancer 2004;101:51-57.
Nayak SK, Naik R, Upadhyaya K, Raghuveer CV, Pai MR. FNAC diagnosis of mucinous carcinoma of the male breast—a case report. Indian J Pathol Microbiol 2001;44:355-357.
Gupta RK, Naran S, Lallu S, Fauck R. Needle aspiration cytodiagnosis of mucinos (colloid) carcinoma of male breast. Pathology 2003;6:539-540.
Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A. Cancer statistics 2004 Cancer J Clin 2004;54:8-29.
Simon MS, McKnight E, Schwartz A, Martino S, Swanson GM. Racial differences in cancer of the male breast-15 year experience in the Detroit metropolitan area. Breast Cancer Res Treat 1992;21:55-62.
Sasco AJ, Lowenfels AB, Passer-de-Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993;53:538-549.
Hultborn R, Hanson C, Kopf I, Verbiene I, Warnhammar E, Weimarck A. Prevalence of Klinefelter’s syndrome in male breast cancer patients. Anticancer Res 1997;17:4293.
Hsing AW, McLaughlin JK, Cocco P, Co Chien HT, Fraumeni JF Jr. Risk factors for male breast cancer (United States).Cancer Causes Control 1998;9:269-275.
Ewertz M, Holmberg L, Tretli S, Pedersen BV, Kristensen A. Risk factors for male breast cancer-a case-control study from Scandinavia.Acta Oncol 2001;40:467-471.
Basham VM, Lipscombe JM, Ward JM, Gayther SA, Ponder BAJ, Easton DF, Pharoah PDP. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 2002;4:R2.
Giordano SH, Buzdar MD, Hortobagy GN. Breast Cancer in Men Ann Intern Med 2002;137:678-687.
Rosen PP. Carcinoma de la mama masculina en patología mamaria de Rosen Segunda Ed. Tomo II AMOLCA, Colombia 2005. p. 713-728.
Koc M, Öztas S, Erem MT, Ciftcioglu MA, Onuk MD. Invasive lobular carcinoma of the male breast: a case report Jpn J Oncol 2001;31:444-446.
Adsay NV, Merati K, Nassr H, et al. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs. Am J Surg Pathol 2003;27:571-578.
Rosai J. Breast en Rosai and Ackerman’s surgical pathology. Ninth ed. Vol 2 Mosby, China, 2004. p. 1805-1807.
Piña-Oviedo S, Ortiz-Hidalgo C. Biomarcadores como factores pronósticos y predictivos en carcinoma de la glándula mamaria. Criterios actuales de interpretación por inmunohistoquímica. Patología (Revista latinoamericana) 2006;44:45-59.